News

For the last three years, one piece of hardware has continually earned credit for the rise of generative artificial intelligence (AI) applications: the semiconductor. Naturally, investors sought

On November 14, California-based Tensile Capital Management disclosed a buy of 160,559 shares of Vertex (NASDAQ:VERX) in the third quarter. Despite the expanded stake, the market value of the

There are compelling reasons for some investors to consider investing in Medtronic (NYSE: MDT), depending on their goals and risk tolerance. It is a well-established healthcare leader that generates

New York City-based Newtyn Management reported a buy of nearly 1.6 million additional Indivior PLC shares, increasing its position by an estimated $62.8 million in the third quarter, according to a

On November 14, New York City-based Newtyn Management disclosed a purchase of 994,332 shares of QuidelOrtho Corporation (QDEL), increasing its stake by approximately $30.4 million.

According to a

With energy demand surging globally, nuclear power is one energy source that checks all of the boxes. That's because it provides reliable, carbon-free power, providing consistent baseload energy

Merck (NYSE: MRK) has taken its shareholders on a wild ride of late -- from last March's record high of more than $130 to this May's low near $76 back to its current price of just a little more than

Vertex Pharmaceuticals (NASDAQ: VRTX) has grown revenue and profit into the billions of dollars thanks to its expertise in the treatment of cystic fibrosis (CF). The company has developed a

It's inaccurate to call the largest health insurer in the country and the fourth-largest healthcare company by market cap an underdog. However, UnitedHealth Group (NYSE: UNH) looked more like an

Over the last three months, the S&P 500 healthcare sector has risen 13%, compared to the broader S&P 500 index's 7% increase.

However, one stock that hasn't matched its sector's returns is Halozyme

Pharmaceutical stocks have been on fire this year. The iShares U.S. Pharmaceuticals ETF (NYSEMKT: IHE), which tracks 43 drugmakers, is up almost 29% year to date and 11% over the past month.

There

When OpenAI released ChatGPT to the masses at the end of November 2022, Palantir Technologies (NASDAQ: PLTR) had a $12.5 billion market capitalization. Today, the data-mining darling is worth more

The pharmaceutical industry is highly competitive, and currently, the leading company in the sector is likely Eli Lilly (NYSE: LLY). That's driven by the fact that Eli Lilly makes the weight loss

Did you know that Summit Therapeutics (NASDAQ: SMMT) is one of the few publicly traded companies that has a market cap of more than $10 billion, but no revenue? With that kind of a valuation and

Are things finally looking up for Merck (NYSE: MRK)? After being mostly southbound for the better part of the last two years, the pharmaceutical giant is showing signs of life. Over the past month

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD), CoreWeave (NASDAQ: CRWV), and other AI stocks. To learn more, check out the short video, consider

The past few years have been a challenging ride for Pfizer (NYSE: PFE). Since the company made history in 2022, when it became the first in the biopharma industry to reach $100 billion in annual

Vertex Pharmaceuticals (NASDAQ: VRTX) has proven itself to be an excellent long-term investment, advancing 91% over the past five years. This is as the company has delivered steady growth in revenue

One effective way to earn solid, long-term returns is to invest in dividend-paying stocks since reinvesting the payout can help boost stock performance. However, they aren't all created equal, and

Medtronic (NYSE: MDT), a medical device specialist, has lagged the market over the past five years. The company has experienced slow revenue growth, significant competition in some of its niches --

President Trump recently announced an executive order to initiate the Genesis Mission, a federal initiative under the Department of Energy, aimed at accelerating the development of artificial